VM

Vatsal Mehulkumar Rav

Active Director Director DIN 11605922
DIN 11605922 First appointment Mar 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Vatsal Mehulkumar Rav

Data last updated:

Vatsal Mehulkumar Rav is a Director at Ravyas Pharma Projects Limited (since 2026).

DIN 11605922
Primary Designation Director
First Appointment 13 Mar 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ravyas Pharma Projects Limited U71100GJ2026PLC174912
Director13 Mar 20262026Active

Directorship timeline

Open interactive timeline →
Ravyas Pharma Projects Limited
Premium access

Shareholding and investment profile for Vatsal Mehulkumar Rav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vatsal Mehulkumar Rav

Vatsal Mehulkumar Rav currently holds 1 directorship: Ravyas Pharma Projects Limited (Director, since 13 Mar 2026).

Vatsal Mehulkumar Rav was first appointed on 13 Mar 2026 as Director at Ravyas Pharma Projects Limited.

The current boards of Vatsal Mehulkumar Rav's companies include Devyani Bankimchandra Vyas (Ravyas Pharma Projects Limited), Dhruv Mehulkumar Rav (Ravyas Pharma Projects Limited), Hemantkumar Shantilal Patel (Ravyas Pharma Projects Limited), Mehulkumar Mahendraprasad Rav (Ravyas Pharma Projects Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available